IP Verse

Arena Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Arena Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest patents of Arena Pharmaceuticals opposed by its competitors

Explore Arena Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3582814May 1, 2024Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal Manifestations2
EP3860590Jun 7, 2023Methods For The Treatment Of Scleroderma2
EP3310760Oct 19, 2022Crystalline L-Arginine Salt Of (R)-2-(7-(4-Cyclopentyl-3-(Trifluoromethyl)Benzyloxy)-1,2,3,4-Tetrahydrocyclo-Penta[B]Indol-3-Yl)Acetic Acid(Compound1) For Use In Sipi Receptor-Associated Disorders2

Top competitors of Arena Pharmaceuticals